Efficiency of natural oils as alternative adjuvants to mineral oils in inactivated avian influenza vaccine formulation

References

• Aluyor, E., and M. Ori-jesu. 2009. “Biodegradation of Mineral Oils – a Review.” African Journal of Biotechnology 8:915–920. https://academicjournals.org/journal/AJB/article-full-text-pdf/E10A8E06603.
   Google Scholar
• Barclay, T., and N. Petrovsky. 2017. “Chapter-7 Vaccine Adjuvant Nanotechnologies.” In Micro and Nanotechnology in Vaccine Development, 127–147. https://doi.org/10.1016/B978-0-323-39981-4.00007-5.
   Google Scholar
• Blanco-lobo, P., A. Nogales, L. Rodríguez, and L. Martínez-sobrido. 2019. “Novel Approaches for the Development of Live Attenuated Influenza Vaccines.” Viruses 11 (2): 190. https://doi.org/10.3390/v11020190.
   PubMed Web of Science ®Google Scholar
• Burakova, Y., R. Madera, S. McVey, J. R. Schlup, and J. Shi. 2018. “Adjuvants for Animal Vaccines.” Viral Immunology 31 (1): 11–22. https://doi.org/10.1089/vim.2017.0049.
   PubMed Web of Science ®Google Scholar
• CDC, NCIRD. 2022. “Bird Flu Virus Infections in Humans.” June 20, 2022. https://www.cdc.gov/flu/avianflu/avian-in-humans.htm.
   Google Scholar
• Dupuis, L., S. Ascarateil, J. Aucouturier, and V. Ganne. 2006. “SEPPIC Vaccine Adjuvants for Poultry.” Annals of the New York Academy of Sciences 1081 (1): 202–205.
   PubMedGoogle Scholar
• ECDC, European Centre for Disease Prevention and Control. February 24, 2021. “European Centre for Disease Prevention and Control. First Identification of Human Cases of Avian Influenza a (H5N8) Infection.” https://www.ecdc.europa.eu/sites/default/files/documents/First-identification-human-cases-avian-influenza-A-H5N8-infection.pdf.
   Google Scholar
• Fukumi, H. 1976. “Experience of Nasal Application of Inactivated Influenza Vaccine.” Developments in Biological Standardization 33:155–61.
   PubMedGoogle Scholar
• Gomaa, M. R., A. S. el Rifay, D. Abu Zeid, M. A. Elabd, E. Elabd, A. Kandeil, N. M. A. Shama, et al. 2020. “Incidence and Seroprevalence of Avian Influenza in a Cohort of Backyard Poultry Growers, Egypt, August 2015–March 2019.” Emerging Infectious Diseases 26 (9): 2129–2136. https://doi.org/10.3201/eid2609.200266.
   PubMed Web of Science ®Google Scholar
• Hashimoto, M., K. Hirota, H. Yoshitomi, S. Maeda, S. Teradaira, S. Akizuki, P. Prieto-martin, et al. 2010. “Complement Drives Th17 Cell Differentiation and Triggers Autoimmune Arthritis.” Journal of Experimental Medicine 207 (6): 1135–1143. https://doi.org/10.1084/jem.20092301.
   PubMed Web of Science ®Google Scholar
• Jafari, M., M. Moghaddam Pour, M. Taghizadeh, S. Masoudi, and Z. Bayat. 2017. “Comparative Assessment of Humoral Immune Responses of Aluminum Hydroxide and Oil-Emulsion Adjuvants in Influenza (H9N2) and Newcastle Inactive Vaccines to Chickens.” Artificial Cells, Nanomedicine & Biotechnology 45 (1): 84–89.
   PubMed Web of Science ®Google Scholar
• Kandeil, A., J. T. Hicks, S. G. Young, A. N. el Taweel, A. S. Kayed, Y. Moatasim, O. Kutkat, et al. 2019. “Active Surveillance and Genetic Evolution of Avian Influenza Viruses in Egypt, 2016–2018.” Emerging Microbes & Infections 8 (1): 1370–1382. https://doi.org/10.1080/22221751.2019.1663712.
   PubMed Web of Science ®Google Scholar
• Kandeil, A., Y. Moatasim, A. el Taweel, M. el Sayes, A. Rubrum, T. Jeevan, P. P. McKenzie, et al. 2022. “Genetic and Antigenic Characteristics of Highly Pathogenic Avian Influenza A(H5N8) Viruses Circulating in Domestic Poultry in Egypt, 2017–2021.” Microorganisms [Internet] 10 (3): 595. https://www.mdpi.com/2076-2607/10/3/595.
   PubMed Web of Science ®Google Scholar
• Kandeil, A., J. S. M. Sabir, A. Abdelaal, E. H. Mattar, A. N. el-taweel, M. J. Sabir, A. Aly Khalil, R. Webby, G. Kayali, and M. A. Ali. 2018. “Efficacy of Commercial Vaccines Against Newly Emerging Avian Influenza H5N8 Virus in Egypt.” Scientific Reports 8 (1): 9697. https://doi.org/10.1038/s41598-018-28057-x.
   PubMedGoogle Scholar
• Les Sims, A. T., S. von Dobschuetzb, E. Gardnerb, and R. Aguannob. 2016. “Rational Use of Vaccination for Prevention and Control of H5 Highly Pathogenic Avian Influenza.”
   Google Scholar
• Liu, C. G., M. Liu, F. Liu, D. F. Liu, Y. Zhang, W. Q. Pan, H. Chen, C. H. Wan, E. C. Sun, and H. T. Li. 2011. “Evaluation of Several Adjuvants in Avian Influenza Vaccine to Chickens and Ducks.” Virology Journal 8 (1): 1–6.
   PubMedGoogle Scholar
• Lone, N. A., E. Spackman, and D. Kapczynski. 2017. “Immunologic Evaluation of 10 Different Adjuvants for Use in Vaccines for Chickens Against Highly Pathogenic Avian Influenza Virus.” Vaccine: X 35 (26): 3401–3408. https://doi.org/10.1016/j.vaccine.2017.05.010.
   Google Scholar
• Mady, W., A. Arafa, A. S. Hussein, M. M. Aly, and H. Madbouly. 2013. “Nigella Sativa Oil as an Immunostimulant Adjuvant in H5 Based DNA Vaccine of H5N1 Avian Influenza Virus.” Global Veterinaria 10:663–668. https://doi.org/10.5829/idosi.gv.2013.10.6.73101.
   Google Scholar
• OIE. 2021. “Avian Influenza. (Including Infection with High Pathogenicity Avian).” In OIE Terrestrial Manual, edited by World Organisation for Animal Health OIE, Vol. 26. https://www.oie.int/fileadmin/Home/eng/Health_standards/tahm/3.03.04_AI.pdf.
   Google Scholar
• OIE, World Organisation for Animal Health. 2013. “OIE Information Document on Avian Influenza Vaccination.” (France). https://www.woah.org/app/uploads/2013/04/guidelines20on20ai20vaccination.pdf.
   Google Scholar
• Pope, B. L., E. Chourmouzis, J. Sigindere, R. J. Capetola, and C. Y. Lau. 1992. “In vivo Enhancement of Murine Natural Killer Cell Activity by 7-Allyl-8-Oxoguanosine (Loxoribine).” International Journal of Immunopharmacology 14 (8): 1375–82. https://doi.org/10.1016/0192-0561(92)90008-9.
   PubMed Web of Science ®Google Scholar
• Pulendran, B., P. S. Arunachalam, and D. T. o’hagan. 2021. “Emerging Concepts in the Science of Vaccine Adjuvants.” Nature Reviews Drug Discovery 20 (6): 454–475. https://doi.org/10.1038/s41573-021-00163-y.
   PubMed Web of Science ®Google Scholar
• Rabrenović, B. B., E. B. Dimić, M. M. Novaković, V. V. Tešević, and Z. N. Basić. 2014. “The Most Important Bioactive Components of Cold Pressed Oil from Different Pumpkin (Cucurbita Pepo L.) Seeds.” LWT - Food Science & Technology 55 (2): 521–527. https://doi.org/10.1016/j.lwt.2013.10.019.
   Web of Science ®Google Scholar
• Ranganathan, V., S. Selvasubramanian, and S. Vasanthakumar. 2013. “Estimation of Humoral Immune Response in Rabbits Fed with Cucurbita Maxima Seeds.” Veterinary World 6:396. https://doi.org/10.5455/vetworld.2013.396-399.
   Google Scholar
• Salaheldin, A. H., A. R. Elbestawy, A. M. Abdelkader, H. A. Sultan, A. A. Ibrahim, H. S. abd el-hamid, and E. M. Abdelwhab. 2022. “Isolation of Genetically Diverse H5N8 Avian Influenza Viruses in Poultry in Egypt, 2019-2021.” Viruses 14 (7). https://doi.org/10.3390/v14071431.
   PubMed Web of Science ®Google Scholar
• Scoones, I. 2010. Avian Influenza: Science, Policy and Politics. London: Earthscan.
   Google Scholar
• Selim, A. A., A. M. Erfan, N. Hagag, A. Zanaty, A. H. Samir, M. Samy, A. Abdelhalim, et al. 2017. “Highly Pathogenic Avian Influenza Virus (H5N8) Clade 2.3.4.4 Infection in Migratory Birds, Egypt.” Emerging Infectious Diseases 23 (6): 1048–1051. https://doi.org/10.3201/eid2306.162056.
   PubMed Web of Science ®Google Scholar
• Shakya, A. K., and K. S. Nandakumar. 2013. “Applications of Polymeric Adjuvants in Studying Autoimmune Responses and Vaccination Against Infectious Diseases.” Journal of the Royal Society Interface 10 (79): 20120536–20120536. https://doi.org/10.1098/rsif.2012.0536.
   PubMed Web of Science ®Google Scholar
• Songhua, H., C. Zhang. 2015. “Vegetable Oil Adjuvant Containing Ginsenoside and Preparation Method and Application Thereof.” China Filed 2015-07-09 and Issued 2015-07-09.
   Google Scholar
• Spackman, E. 2014. “A Brief Introduction to Avian Influenza Virus.” In Animal Influenza Virus, edited by E. Spackman, 61–68. New York, NY: Springer New York.
   Google Scholar
• Stone, H. D. 1993. “Efficacy of Experimental Animal and Vegetable Oil-Emulsion Vaccines for Newcastle Disease and Avian Influenza.” Avian Diseases 37 (2): 399–405.
   PubMed Web of Science ®Google Scholar
• Stone, H. D., M. Brugh, S. R. Hopkins, H. W. Yoder, and C. W. Beard. 1978. “Preparation of Inactivated Oil-Emulsion Vaccines with Avian Viral or Mycoplasma Antigens.” Avian Diseases 22 (4): 666–674. https://doi.org/10.2307/1589643.
   PubMed Web of Science ®Google Scholar
• Swayne, D. E., G. Pavade, K. Hamilton, B. Vallat, and K. Miyagishima. 2011. “Assessment of National Strategies for Control of High-Pathogenicity Avian Influenza and Low-Pathogenicity Notifiable Avian Influenza in Poultry, with Emphasis on Vaccines and Vaccination.” Revue Scientifique Et Technique (International Office of Epizootics) 30 (3): 839–70. https://doi.org/10.20506/rst.30.3.2081.
   PubMed Web of Science ®Google Scholar
• Tamam, S. M., A. S. Hussein, A. M. Arafa, and H. M. Madbouly. 2015. “Preparation and Evaluation of Inactivated Avian Metapneumovirus Vaccine from Recently Isolated Egyptian Strain.” The Journal of Applied Poultry Research 24 (2): 168–176. https://doi.org/10.3382/japr/pfv019.
   Web of Science ®Google Scholar